Cardiovascular response during hemodialysis and hemofiltration: thermal, membrane, and catecholamine influences.
Nine patients on regular dialysis were studied, in a cross-over format comparing hemodialysis (HD) and hemofiltration (HF), to identify potential mechanisms of the disparate hemodynamic responses. Dialysis and substitution fluid composition (high sodium, acetate), treatment time, fluid loss rate, and membrane type (AN 69) were matched. Cardiac output was determined by changes in thoracic electrical bioimpedance. Cardiac output remained stable during HF but increased during HD (p < 0.001, HD vs. HF), despite a parallel reduction in stroke volume. The heart rate response was significantly greater during HD relative to HF (p < 0.01). Systemic vascular resistance remained stable during HF but decreased significantly during HD (p < 0.05). Although there was a modest fall during HD, the difference in blood pressure at the end of treatment between HD and HF was not significant. Comparable increases in body temperature were observed during both treatments. Plasma catecholamines increased in parallel during HD and HF and following orthostatic stimulation at the end of treatment, and extracorporeal catecholamine clearances were similar. The values for serum sodium, total CO2, anion gap, potassium, and hematocrit at the end of treatment were similar, whereas total serum calcium was significantly greater following HD. There were no significant differences in indices of myocardial contractility or central blood volume. These results suggest that the disparate hemodynamic responses to fluid and solute removal during HD and HF can be dissociated from changes in osmolality or venous tone, membrane bioincompatibility, thermal stress, or differences in acetate delivery or catecholamine release. The explanation for the disparate hemodynamic responses between these two treatment modalities remains unclear. A role for an as yet unidentified vasodilatory substance generated during dialysate exposure, or convectively removed during hemofiltration, remain intriguing possibilities.
Fox
S D
SD
Medical Service, Veterans Affairs Medical Center, San Diego, Calif.
Henderson
L W
LW
D000085:Acetates / Q000494:pharmacology; D000180:Acrylic Resins; D000181:Acrylonitrile / Q000031:analogs & derivatives; D000368:Aged; D000369:Aged, 80 and over; D001341:Autonomic Nervous System / Q000503:physiopathology; D001806:Blood Urea Nitrogen; D001826:Body Fluids; D001831:Body Temperature; D002412:Cations / Q000097:blood; D003928:Diabetic Nephropathies / Q000097:blood / Q000503:physiopathology / Q000628:therapy; D003929:Diabetic Neuropathies / Q000503:physiopathology; D015312:Hemodialysis Solutions / Q000494:pharmacology; D006439:Hemodynamics; D006440:Hemofiltration; D006801:Humans; D006973:Hypertension / Q000150:complications; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood*; D006435:Renal Dialysis; D015431:Weight Loss
D000085:Acetates; D000180:Acrylic Resins; D002412:Cations; D015312:Hemodialysis Solutions; C016892:AN-69; D000181:Acrylonitrile; D009638:Norepinephrine